Expression analysis of VEGFA, FGF2, TGFβ1, EGF and IGF1 in human nasal polyposis

Oncology Reports

Volumn 19, Issue 2, 2008, Pages 385-391

  Zaravinos, Apostolos ^a   Soufla, Giannoula ^a   Bizakis, John ^b   Spandidos, Demetrios A ^a  

^a UNIVERSITY OF CRETE   (Greece)

^b UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

Author keywords

Epidermal growth factor; Fibroblast growth factor 2; Gene expression; Insulin like growth factor 1; Nasal polyps; Real time PCR; Transforming growth factor 1; Vascular endothelial growth factor A

Indexed keywords

CYTOKINE; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; MESSENGER RNA; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN A;

ADULT; AGED; ARTICLE; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; NOSE MUCOSA; NOSE POLYP; POLYPECTOMY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION; TURBINATE;

EID: 38749120199     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.19.2.385     Document Type: Article

References (23)

1. Settipane GA, Lund VJ, Bernstein JM and Tos M (eds): Nasal Polyps: Epidemiology, Pathogenesis and Treatment. OceanSide Publications Inc., Providence, RI, 1997.
2. Larsen PL and Tos M: Origin of nasal polyps. Laryngoscope 101: 305-312, 1991.
3. Fokkens W, Lund V, Bachert C, et al: EAACI position paper on rhinosinusitis and nasal polyps executive summary. Allergy 60: 583-601, 2005.
4. Folkman J: What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82: 4-6, 1990.
5. Carmeliet P and Jain RK: Angiogenesis in cancer and other diseases. Nature 407: 249-257, 2000.
6. Hoshino M, Nakamura Y and Hamid QA: Gene expression of vascular endothelial growth factor and its receptors and angiogenesis in bronchial asthma. J Allergy Clin Immunol 107: 1034-1038, 2001.
7. Chetta A, Zanini A, Foresi A, et al: Vascular component of airway remodeling in asthma is reduced by high dose of fluticasone. Am J Respir Crit Care Med 167: 751-757, 2003.
8. Wittekindt C, Hess A, Bloch W, Sultanie S and Michel O: Immunohistochemical expression of VEGF and VEGF receptors in nasal polyps as compared to normal turbinate mucosa. Eur Arch Otorhinolaryngol 259: 294-298, 2002.
9. Nakagawa T, Yamane H, Nakai Y, Shigeta T, Takashima T and Takeda Z: Comparative assessment of cell proliferation and accumulation of extracellular matrix in nasal polyps. Acta Otolaryngol 538 (Suppl): 205-208, 1998.
10. Coste A, Rateau JG, Bernaudin JF, Peynegre R and Escudier E: Nasal polyposis pathogenesis: a flow cytometric and immunohistochemical study of epithelial cell proliferation. Acta Otolaryngol 116: 755-761, 1996.
11. Elovic A, Wong DT, Weller PF, Matossian K and Galli SJ: Expression of transforming growth factors-alpha and beta 1 messenger RNA and product by eosinophils in nasal polyps. J Allergy Clin Immunol 93: 864-869, 1994.
12. Coste A, Wang QP, Roudot-Thoraval F, et al: Epithelial cell proliferation in nasal polyps could be up-regulated by platelet-derived growth factor. Laryngoscope 106: 578-583, 1996.
13. Petruson B, Hansson HA and Petruson K: Insulin-like growth factor I immunoreactivity in nasal polyp. Arch Otolaryngol Head Neck Surg 114: 1272-1275, 1988.
14. Zaravinos A, Bizakis J, Soufla G, Sourvinos G and Spandidos DA: Mutations and differential expression of the ras family genes in human nasal polyposis. Int J Oncol 31: 1051-1059, 2007.
15. Lee JY, Lee SH, Lee HM, et al: Analysis of gene expression profiles of normal human nasal mucosa and nasal polyp tissues by SAGE. J Allergy Clin Immunol 118: 134-142, 2006.
16. Szefler SJ: Airway remodelling: therapeutic target or not? Am J Respir Crit Care Med 171: 672-673, 2005.
17. Coste A, Brugel L, Maitre B, Boussat S, Papon JF, Wingerstmann L, Peynegre R and Escudier E: Inflammatory cells as well as epithelial cells in nasal polyps express vascular endothelial growth factor. Eur Respir J 15: 367-372, 2000.
18. Dvorak HF, Detmar M, Claffey KP, Nagy JA, van de Water L and Senger DR: Vascular permeability factor/vascular endothelial growth factor: an important mediator of angiogenesis in malignancy and inflammation. Int Arch Allergy Immunol 107: 233-235, 1995.
19. Ohno I, Lea RG, Flanders KC, et al: Eosinophils in chronically inflamed human upper airway tissues express transforming growth factor β1 gene (TGF-β). J Clin Invest 89: 1662-1668, 1992.
20. Serpero L, Petecchia L, Sabatini F, Giuliani M, Silvestri M, Di Blasi P, Rossi GA: The effect of transforming growth factor (TGF)-beta1 and (TGF)-beta2 on nasal polyp fibroblast activities involved upper airway remodeling: modulation by fluticasone propionate. Immunol Lett 105: 61-67, 2006.
21. Kim HJ, Jung HH and Lee SH: Expression of acidic fibroblast growth factor and basic fibroblast growth factor in nasal polyps. Acta Otolaryngol 126: 600-605, 2006.
22. Gajdusek CM, Luo Z and Mayberg MR: Basic fibroblast growth factor and transforming growth factor beta-l: synergistic mediators of angiogenesis in vitro. J Cell Physiol 157: 133-144, 1993.
23. Burgel PR, Escudier E, Coste A, et al: Relation of epidermal growth factor receptor expression to goblet cell hyperplasia in nasal polyps. J Allergy Clin Immunol 106: 705-712, 2000.